Form 8-K REPROS THERAPEUTICS INC. For: May 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Repros Therapeutics (RPRX) Tops Q1 EPS by 2c
May 10, 2016 9:21 AM EDTRepros Therapeutics (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
... More